About this trial
This prospective, comparative study aims to evaluate the postoperative analgesic efficacy of ultrasound-guided Adductor Canal Block (ACB) combined with iPACK block versus Femoral Triangle Block (FTB) combined with selective tibial nerve block and obturator nerve block in patients undergoing arthroscopic anterior cruciate ligament (ACL) reconstruction. The primary objective is to determine which regional anesthesia regimen provides superior pain relief at rest and during movement. The secondary objectives include assessing morphine consumption, motor blockade using the Bromage score, patient satisfaction, and potential adverse effects of these anesthesia techniques.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 16 years and older
Patients undergoing elective arthroscopic anterior cruciate ligament (ACL) reconstruction
ASA physical status I-II
Indicated for spinal anesthesia
Disqualifiers
Infection at the injection site
Spinal cord or lower limb nerve injury
Contraindications to regional anesthesia (Levobupivacaine)
Known allergy to Paracetamol or Diclofenac
Trial design
Parallel
Treatments tested in this trial
Ultrasound-guided Adductor Canal Block (ACB)
Procedure/SurgeryUltrasound-guided administration of 10 mL levobupivacaine 0.2% into the adductor canal space to provide postoperative analgesia
Ultrasound-guided iPACK block
Procedure/SurgeryUltrasound-guided administration of 15 mL levobupivacaine 0.2% into the space between the popliteal artery and the posterior capsule of the knee to provide posterior knee analgesia.
Ultrasound-guided Femoral Triangle Block (FTB)
Procedure/SurgeryUltrasound-guided administration of 10 mL levobupivacaine 0.2% at the distal apex of the femoral triangle to provide anterior and medial knee analgesia
Ultrasound-guided Selective Tibial Nerve Block
Procedure/SurgeryUltrasound-guided administration of 5 mL levobupivacaine 0.2% around the tibial nerve in the popliteal fossa
Ultrasound-guided Obturator Nerve Block
Procedure/SurgeryUltrasound-guided administration of 10 mL levobupivacaine 0.2% targeting the anterior and posterior branches of the obturator nerve within the fascial planes between the adductor muscles.
Treatment groups
Trial outcomes
Primary outcomes
Visual Analog Scale (VAS) for Pain at Rest and Movement
Evaluating pain scores using the Visual Analog Scale (VAS) at rest and during knee flexion at 0, 1, 3, 6, 9, 12, 18, and 24 hours postoperatively
Secondary outcomes
Total Rescue Morphine Consumption
Motor Blockade Assessment using Bromage Score
Patient Satisfaction Score
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: